KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $601,960 | -55.3% | 3,560 | -42.6% | 0.00% | 0.0% |
Q2 2023 | $1,345,554 | +48.1% | 6,205 | +24.1% | 0.00% | 0.0% |
Q1 2023 | $908,382 | +1.6% | 5,001 | +10.0% | 0.00% | 0.0% |
Q4 2022 | $893,682 | +37.7% | 4,548 | +57.6% | 0.00% | 0.0% |
Q3 2022 | $649,000 | -97.8% | 2,885 | -98.8% | 0.00% | -97.1% |
Q2 2022 | $29,738,000 | -34.6% | 235,067 | -34.5% | 0.03% | -24.4% |
Q1 2022 | $45,451,000 | +22.9% | 358,750 | +27.1% | 0.04% | +32.4% |
Q4 2021 | $36,985,000 | +12522.9% | 282,332 | +11693.3% | 0.03% | – |
Q3 2021 | $293,000 | +2.4% | 2,394 | -4.5% | 0.00% | – |
Q2 2021 | $286,000 | -56.3% | 2,506 | -54.0% | 0.00% | -100.0% |
Q1 2021 | $655,000 | -19.5% | 5,452 | -32.0% | 0.00% | 0.0% |
Q4 2020 | $814,000 | +103.5% | 8,015 | +54.9% | 0.00% | 0.0% |
Q3 2020 | $400,000 | +37.0% | 5,175 | +27.6% | 0.00% | – |
Q1 2020 | $292,000 | +1617.6% | 4,056 | +300.0% | 0.00% | – |
Q3 2019 | $17,000 | – | 1,014 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |